FLYNPOVI

Pharmaceutical preparations for the treatment or prevention of cancer, adenocarcinomas, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, duodenal diseases and disorders, colonic diseases and disorders, rectal diseases and disorders, urological disorders and diseases, gastrointestinal disorders and diseases, and hepatobiliary disorders and diseases; Pharmaceutical preparations to minimize the occurrence, progression, or recurrence of polyps and tumors; Pharmaceutical preparations for use in the treatment of Familial Adenomatous Polyposis and precancerous conditions; Pharmaceutical preparations for use in the prevention and treatment of cancer, precancerous conditions, tumors, polyps, adenomas, inflammation, genetic diseases and disorders, oncological diseases and disorders, and duodenal disease